Profitability
Weight: 15%
D-
30
- 5yr Avg ROIC -31.9%
- Operating Margin Trend +27.33 pp/yr
NTLA
Intellia Therapeutics, Inc.
AlphaQuality composite grade, weighted for high-growth software businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.
Grade overrides the 27.5 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -46.2%
- 5yr Share-Count CAGR 14.1%
Growth Quality
Weight: 35%
C-
50
- 5yr Revenue CAGR 3.1%
- Revenue-Growth Years (5) 3/5
Cash Generation
Weight: 20%
F
0
- 5yr FCF Margin -746.5%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 10%
D
34
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 1.08
Stability
Weight: 5%
D+
39
- Negative-Revenue Years (5) 2/5
- Piotroski F-Score 2
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 2 added; 1 full exit.
- Holders
- 2
- Avg Δ position
- +222.4%
- New buys
- 0
- Full exits
- 1